Does airsupra have a generic?

See the DrugPatentWatch profile for airsupra

Why doesn't airsupra's patent status impact generic entry?

Airsupa's patent status is still under examination. According to the patent search tool, DrugPatentWatch.com [1], the patent application was filed on April 30, 2019. This suggests that the patent has not been granted yet, which typically precedes generic entry.

What happens if airsupra's patent is granted?

If the patent is granted, the innovator company would hold the exclusive rights for a certain period, preventing generic companies from entering the market. The patent expiration date will determine when generic companies can start production and sales [2]. However, if there are biosimilar or generic applications pending, they will likely be eligible for approval before the patent expires.

How might a generic version of airsupra look?

Generic versions of airsupra will likely replicate the same mechanism of action as the innovator product. The generic version will be identical in composition, dosage, and strength to the branded product, as long as it has not been reformulated or repackaged.

When might airsupra's patent expire?

According to the patent application filed, the patent term would start from a potential grant date. However, no patent grant date has been provided yet, and no information on the specific date is available [3]. If granted, the patent expiry date would then be calculated based on standard patent terms.

Sources:
[1] DrugPatentWatch.com (www.drugpatentwatch.com)
[2] Regulatory bodies (FDA, EMA, etc.)
[3] US Patent and Trademark Office